FDA Approved: RIVASTIGMINE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approves a supplemental application for rivastigmine submitted by Sandoz Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Parkinson Disease Dementia

Drugs mentioned

• Rivastigmine (Rivastigmine)

Snippet

SUPPL AP for RIVASTIGMINE (RIVASTIGMINE)